Chimerix Operating Expenses 2011-2026 | CMRX

Annual Operating Expenses Chimerix

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
93.4 M	93.8 M	175 M	49.9 M	129 M	78.8 M	76.6 M	83.7 M	129 M	62.9 M	33 M	36.5 M	37.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
175 M	33 M	83 M

Quarterly Operating Expenses Chimerix

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
24.8 M	23 M	24.4 M	-	26.7 M	21.4 M	24.5 M	-	20.6 M	23.9 M	24.7 M	-	18.7 M	18.2 M	98.9 M	-	13.2 M	11.7 M	12.2 M	-	76.5 M	20.1 M	21.2 M	-	17.1 M	20.4 M	21.1 M	-	18.8 M	17.9 M	19.3 M	-	18.1 M	20.4 M	27.9 M	-	35 M	29.1 M	23.6 M	-	18 M	12.5 M	-	-	-	-	8.32 M	-	-	-	8.57 M	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
98.9 M	8.32 M	24.1 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Amgen AMGN	9.33 B	$ 340.0	-0.75 %	$ 183 B	USA
Amneal Pharmaceuticals AMRX	539 M	$ 12.32	-0.24 %	$ 3.86 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	137 M	$ 23.27	-1.63 %	$ 2.96 B	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.36	-2.16 %	$ 362 M	Britain
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.76	4.35 %	$ 9.05 B	Australia
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.57	-3.38 %	$ 16.1 M	USA
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	177 M	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Cellectar Biosciences CLRB	15.3 M	$ 2.75	1.48 %	$ 7.17 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	110 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	47.8 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Cyclerion Therapeutics CYCN	5.63 M	$ 3.48	-16.14 %	$ 8.76 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Dyadic International DYAI	10.1 M	$ 0.88	1.66 %	$ 31.8 M	USA
BioNTech SE BNTX	512 M	$ 89.62	-1.82 %	$ 27.2 B	Germany
Coherus BioSciences CHRS	231 M	$ 1.67	-	$ 196 M	USA
Akari Therapeutics, Plc AKTX	17.3 M	$ 3.8	7.34 %	$ 256 B	Britain
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA